{
  "actions": [
    {
      "acted_at": "2022-11-17",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2022-11-17",
      "action_code": "",
      "committees": [
        "SSJU"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on the Judiciary.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s5123-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Judiciary",
      "committee_id": "SSJU"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "P000603",
      "district": null,
      "name": "Paul, Rand",
      "original_cosponsor": true,
      "sponsored_at": "2022-11-17",
      "state": "KY",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2022-11-17",
  "number": "5123",
  "official_title": "A bill to amend the Controlled Substances Act to modify the registration requirements relating to research, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Breakthrough Therapies Act",
  "sponsor": {
    "bioguide_id": "B001288",
    "district": null,
    "name": "Booker, Cory A.",
    "state": "NJ",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2022-11-17",
  "subjects": [
    "Crime and law enforcement"
  ],
  "subjects_top_term": "Crime and law enforcement",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2022-11-17",
    "date": "2023-09-01T18:18:06Z",
    "text": "Breakthrough Therapies Act\n\nThis bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. It also provides for expedited controlled substance registrations through the Drug Enforcement Administration for researchers whose work involves investigational drugs."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Breakthrough Therapies Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Breakthrough Therapies Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Controlled Substances Act to modify the registration requirements relating to research, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2023-09-01T18:30:31Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s5123.xml"
}